Israel: Shizim Launches Medical Cannabis Incubator Cann10

The Israeli biomed group's incubator will provide startups with mentoring and consultation, and help them find investors.

Shizim Group, managed by CEO Yossi Bornstein, which comprises more than ten biomed companies, has launched the Cann10 incubator for medical cannabis companies. The incubator will not directly invest in companies, but will provide them with mentoring and consultation, and help them find relevant investors.

Shizim is a multi-disciplinary biomed group, consisting of companies dealing with drug and medical equipment marketing in Israel (including Dolphin Medical Ltd. and Biotis Ltd., the former distributer of Bristol-Myers products in Israel), investments in startup (inter alia, together with a Polish venture capital fund), providing startups with consultation, medical trial consultation and training and the undertaking of clinical trial via GCP Clinical Studies Ltd.. It has begun medical cannabis operations in recent year.

"A monumental change"

"The past few years have seen a monumental change...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.